BHPA — Aquiva Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End null | Unit | null | null | null | null | null | nullE | nullE | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aquiva Group , Inc, formerly BHPA, Inc., is a biotech company. The Company is focused on commercializing materials science technologies related to next-generation patches for transdermal drug delivery systems (TDDS). Leveraging its proprietary Hydrogel with Inter-Penetrating Network Anchor (HiPNA) technology toward the development of products to satisfy the unmet needs in wound care, skin care, as well as healthcare markets. It has developed a novel hydrogel material, AQUIPHER, with many properties that surpasses industry standards, making AQUIPHER an ideal material for various applications, including moist wound dressings, and active ingredient-releasing patches for skin care, wound care, sleep aid and health supplements, and transdermal drugs. Its subsidiary is Aquiva Medical Inc.
Directors
- Last Annual
- Last Interim
- Incorporated
- November 7th, 2005
- Public Since
- May 16th, 2007
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 3,826,281,559
- Address
- 9th Floor, Suite 1550, MIAMI, 33131
- Web
- Phone
- +1 3053972818
- Auditors
Upcoming Events for BHPA
Similar to BHPA
Actavia Life Sciences
Pink Sheets on Nasdaq
Acura Pharmaceuticals
Pink Sheets on Nasdaq
Adhera Therapeutics
Pink Sheets on Nasdaq
Ramoil Management
Pink Sheets on Nasdaq
Adynxx
Pink Sheets on Nasdaq
FAQ
As of Today at 07:35 UTC, shares in Aquiva are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Aquiva last closed at $0.00 and the price had moved by -51.79% over the past 365 days. In terms of relative price strength the Aquiva share price has underperformed the S&P500 Index by -54.96% over the past year.
There is no consensus recommendation for this security.
Find out moreAquiva does not currently pay a dividend.
Aquiva does not currently pay a dividend.
Aquiva does not currently pay a dividend.
To buy shares in Aquiva you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Aquiva had a market capitalisation of .
Here are the trading details for Aquiva:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: BHPA
Based on an overall assessment of its quality, value and momentum Aquiva is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aquiva. Over the past six months, its share price has underperformed the S&P500 Index by -17.89%.
As of the last closing price of $0.00, shares in Aquiva were trading -56.89% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Aquiva PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Aquiva's management team is headed by:
- Alejandro Aparicio - CEO
- James Pierce - CFO
- David Craven - SEC
- Massimiliano Pozzoni - DRC